Annual Retained Earnings
-$900.88 M
-$150.66 M-20.08%
December 31, 2022
Summary
- As of February 10, 2025, ORTX annual retained earnings is -$900.88 million, with the most recent change of -$150.66 million (-20.08%) on December 31, 2022.
- During the last 3 years, ORTX annual retained earnings has fallen by -$447.22 million (-98.58%).
Performance
ORTX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Retained Earnings
-$965.92 M
-$35.32 M-3.80%
September 30, 2023
Summary
- As of February 10, 2025, ORTX quarterly retained earnings is -$965.92 million, with the most recent change of -$35.32 million (-3.80%) on September 30, 2023.
- Over the past year, ORTX quarterly retained earnings has dropped by -$72.92 million (-8.17%).
Performance
ORTX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
ORTX Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -20.1% | -8.2% |
| 3 y3 years | -98.6% | -68.9% |
| 5 y5 years | -1407.9% | - |
ORTX Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | +20.1% | at low | +28.8% | at low |
| 5 y | 5-year | +98.6% | at low | +112.9% | at low |
| alltime | all time | +4483.0% | at low | +1516.8% | at low |
Orchard Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | -$965.92 M(+3.8%) |
| Jun 2023 | - | -$930.60 M(+1.3%) |
| Mar 2023 | - | -$918.30 M(+1.9%) |
| Dec 2022 | -$900.88 M(+20.1%) | -$900.88 M(+0.9%) |
| Sep 2022 | - | -$893.00 M(+5.6%) |
| Jun 2022 | - | -$845.44 M(+6.4%) |
| Mar 2022 | - | -$794.52 M(+5.9%) |
| Dec 2021 | -$750.22 M(+23.9%) | -$750.22 M(+5.1%) |
| Sep 2021 | - | -$713.88 M(+5.4%) |
| Jun 2021 | - | -$677.43 M(+5.7%) |
| Mar 2021 | - | -$640.82 M(+5.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | -$605.64 M(+33.5%) | -$605.64 M(+5.9%) |
| Sep 2020 | - | -$572.02 M(+3.7%) |
| Jun 2020 | - | -$551.73 M(+9.4%) |
| Mar 2020 | - | -$504.23 M(+11.1%) |
| Dec 2019 | -$453.66 M(+56.3%) | -$453.66 M(+11.1%) |
| Sep 2019 | - | -$408.25 M(+9.9%) |
| Jun 2019 | - | -$371.51 M(+15.7%) |
| Mar 2019 | - | -$320.98 M(+10.6%) |
| Dec 2018 | -$290.24 M(+385.8%) | -$290.24 M(+25.7%) |
| Jun 2018 | - | -$230.94 M(+286.6%) |
| Dec 2017 | -$59.74 M(+203.9%) | -$59.74 M |
| Dec 2016 | -$19.66 M | - |
FAQ
- What is Orchard Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Orchard Therapeutics?
- What is Orchard Therapeutics annual retained earnings year-on-year change?
- What is Orchard Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Orchard Therapeutics?
- What is Orchard Therapeutics quarterly retained earnings year-on-year change?
What is Orchard Therapeutics annual retained earnings?
The current annual retained earnings of ORTX is -$900.88 M
What is the all time high annual retained earnings for Orchard Therapeutics?
Orchard Therapeutics all-time high annual retained earnings is -$19.66 M
What is Orchard Therapeutics annual retained earnings year-on-year change?
Over the past year, ORTX annual retained earnings has changed by -$150.66 M (-20.08%)
What is Orchard Therapeutics quarterly retained earnings?
The current quarterly retained earnings of ORTX is -$965.92 M
What is the all time high quarterly retained earnings for Orchard Therapeutics?
Orchard Therapeutics all-time high quarterly retained earnings is -$59.74 M
What is Orchard Therapeutics quarterly retained earnings year-on-year change?
Over the past year, ORTX quarterly retained earnings has changed by -$72.92 M (-8.17%)